Cheng Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Cheng Chen has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Honghua Zhang
School of Pharmacy, Hangzhou Normal University, Hangzhou, China; Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines, Engineering Laboratory of Development and Application of Traditional Chinese Medicines, Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang Province, Hangzhou Normal University, Hangzhou, Zhejiang, 311121, China
2 shared publications - Shuling Wang
School of Pharmacy, Zhejiang Provincial Key Laboratory of Anti-Cancer Chinese Medicines and Natural Medicines, Hangzhou Normal University
2 shared publications - Huijuan Cheng
College of pharmacy, Hangzhou Normal University, Hangzhou 311121, China
1 shared publication - Minhui Li
College of pharmacy, Hangzhou Normal University, Hangzhou 311121, China
1 shared publication - Qian Yang
College of pharmacy, Hangzhou Normal University, Hangzhou 311121, China
1 shared publication - Qingchang Tian
School of Pharmacy, Hangzhou Normal University, Hangzhou 311121, China
1 shared publication
Latest Publications
- 17 September 2023
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 319 (Pt 2) , 117193
Stigmasterol and gastrodin, two major components of banxia-baizhu-tianma decoction, alleviated the excessive phlegm-dampness hypertension by reducing lipid accumulation
- 17 September 2023
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 319 (Pt 2) , 117193
Stigmasterol and gastrodin, two major components of banxia-baizhu-tianma decoction, alleviated the excessive phlegm-dampness hypertension by reducing lipid accumulation
- Open Access
- 14 January 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (2) , 868
Emerging Advances of Detection Strategies for Tumor-Derived Exosomes
Exosomes derived from tumor cells contain various molecular components, such as proteins, RNA, DNA, lipids, and carbohydrates. These components play a crucial role in all stages of tumorigenesis and development. Moreover, they reflect the physiological and pathological status of parental tumor cells. Recently, tumor-derived exosomes have become popular biomarkers for non-invasive liquid biopsy and the diagnosis of numerous cancers. The interdisciplinary significance of exosomes research has also attracted growing enthusiasm. However, the intrinsic nature of tumor-derived exosomes requires advanced methods to detect and evaluate the complex biofluid. This review analyzes the relationship between exosomes and tumors. It also summarizes the exosomal biological origin, composition, and application of molecular markers in clinical cancer diagnosis. Remarkably, this paper constitutes a comprehensive summary of the innovative research on numerous detection strategies for tumor-derived exosomes with the intent of providing a theoretical basis and reference for early diagnosis and clinical treatment of cancer.
- 14 January 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (2) , 868
Open AccessEmerging Advances of Detection Strategies for Tumor-Derived Exosomes
Exosomes derived from tumor cells contain various molecular components, such as proteins, RNA, DNA, lipids, and carbohydrates. These components play a crucial role in all stages of tumorigenesis and development. Moreover, they reflect the physiological and pathological status of parental tumor cells. Recently, tumor-derived exosomes have become popular biomarkers for non-invasive liquid biopsy and the diagnosis of numerous cancers. The interdisciplinary significance of exosomes research has also attracted growing enthusiasm. However, the intrinsic nature of tumor-derived exosomes requires advanced methods to detect and evaluate the complex biofluid. This review analyzes the relationship between exosomes and tumors. It also summarizes the exosomal biological origin, composition, and application of molecular markers in clinical cancer diagnosis. Remarkably, this paper constitutes a comprehensive summary of the innovative research on numerous detection strategies for tumor-derived exosomes with the intent of providing a theoretical basis and reference for early diagnosis and clinical treatment of cancer.